InsiderSignal.AI

InsiderSignal.ai

BHVN - Biohaven Ltd.

Insider Purchase by Bailey Gregory (Dir)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

3 months ago, Bailey Gregory, serving as Dir at Biohaven Ltd. (BHVN), purchased 400,000 shares at $7.50 per share, for a total transaction value of $3,000,000.00. Following this transaction, Bailey Gregory now holds 2,020,071 shares of BHVN.

This purchase represents a 25.00% increase in Bailey Gregory's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, November 13, 2025 and publicly disclosed via SEC Form 4 filing on Monday, November 17, 2025, 4 days after the trade was made.

Biohaven Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Bailey Gregory

Dir

Gregory H. Bailey, M.D. is an independent director at Biohaven Ltd. (BHVN), serving since September 2022 after previously directing the former parent company since January 2014.[[1]](https://fintool.com/app/research/companies/BHVN/people/gregory-bailey)[[2]](https://www.gurufocus.com/insider/61831/gregory-bailey) Age 69, Dr. Bailey holds an M.D. from the University of Western Ontario and practiced emergency medicine for ten years before transitioning to biotech finance and entrepreneurship.[[1]](https://fintool.com/app/research/companies/BHVN/people/gregory-bailey) Dr. Bailey is CEO and co-founder of Juvenescence Limited, a private life sciences company focused on longevity, and Executive Chairman there as well.[[1]](https://fintool.com/app/research/companies/BHVN/people/gregory-bailey)[[4]](https://juvlabs.com/our-team/dr-gregory-bailey-md/) His career highlights include founding Palantir Group Inc., a biotech merchant bank, co-founding SalvaRx Group Plc, Portage Biotech Inc. (where he serves as Chairman), and Medivation Inc. (director 2005–2012, acquired by Pfizer).[[1]](https://fintool.com/app/research/companies/BHVN/people/gregory-bailey)[[3]](https://mfg.im/team-member/gregory-bailey/)[[4]](https://juvlabs.com/our-team/dr-gregory-bailey-md/) He currently holds directorships at Manx Financial Group, Serina Therapeutics, and Portage Pharmaceuticals, with significant BHVN equity ownership aligning his interests.[[1]](https://fintool.com/app/research/companies/BHVN/people/gregory-bailey)[[2]](https://www.gurufocus.com/insider/61831/gregory-bailey)[[3]](https://mfg.im/team-member/gregory-bailey/) Dr. Bailey chairs Biohaven's Nominating & Corporate Governance Committee and serves on the Audit Committee.[[1]](https://fintool.com/app/research/companies/BHVN/people/gregory-bailey)

View full insider profile →

Trade Price

$7.50

Quantity

400,000

Total Value

$3,000,000.00

Shares Owned

2,020,071

Trade Date

Thursday, November 13, 2025

101 days ago

SEC Filing Date

Monday, November 17, 2025

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Biohaven Ltd.

Company Overview

No company information available
View news mentioning BHVN

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/1246020

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime